T2 lesions and rate of progression of disability in multiple sclerosis

被引:25
|
作者
Mostert, J. P. [1 ,2 ]
Koch, M. W. [1 ]
Steen, C. [1 ]
Heersema, D. J. [1 ]
de Groot, J. C. [3 ]
De Keyser, J. [1 ,4 ]
机构
[1] Univ Groningen, Dept Neurol, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands
[2] Rijnstate Hosp, Dept Neurol, Arnhem, Netherlands
[3] Univ Groningen, Dept Radiol, Univ Med Ctr Groningen, NL-9713 GZ Groningen, Netherlands
[4] Free Univ Brussels, Univ Hosp Brussels, Dept Neurol, Brussels, Belgium
关键词
disease progression; MRI; multiple sclerosis; prognosis; AXONAL LOSS; INTERFERON BETA-1B; PREDICTIVE-VALUE; MRI; DISEASE; TRIAL; ONSET; PHASE; MS;
D O I
10.1111/j.1468-1331.2010.03093.x
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background and purpose: To assess the predictive value of T2 lesions on the rate of progression of disability in multiple sclerosis (MS). Methods: We reanalyzed T2 lesion number and load on brain MRI scans, performed before 1997, of 186 MS patients, who were clinically followed. There were 90 patients with progressive MS (35 secondary progressive and 55 primary progressive), and 96 with relapsing remitting MS. The rate of progression of disability was measured by time to sustained progression of disability (defined as an increase in >= 1 point when the Expanded Disability Status Scale (EDSS) was 5.5 or less and an increase in EDSS of >= 0.5 point when the EDSS was 6.0 or higher), and by the Multiple Sclerosis Severity Score (MSSS). Results: During follow-up (median 15 years, IQR 12-17 years), 94% of the patients with progressive MS and 50% of the patients with relapsing remitting MS had progression of disability. Higher T2 lesion number and load were modestly associated with a higher rate of disease progression on the MSSS and a shorter time to progression of disability in relapsing remitting MS, but not in progressive MS. Conclusions: Our findings indicate that the amount of T2 lesions has a small predictive value for progression of disability in relapsing remitting MS, but has no influence on the rate of progression in progressive MS.
引用
收藏
页码:1471 / 1475
页数:5
相关论文
共 50 条
  • [31] Self-reported health promotion and disability progression in multiple sclerosis
    D'hooghe, Marie Beatrice
    Nagels, Guy
    De Keyser, Jacques
    Haentjens, Patrick
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2013, 325 (1-2) : 120 - 126
  • [32] Chronic lesion activity and disability progression in secondary progressive multiple sclerosis
    Beynon, Vanessa
    George, Ilena C.
    Elliott, Colm
    Arnold, Douglas L.
    Ke, Jun
    Chen, Huaihou
    Zhu, Li
    Ke, Chunlei
    Giovannoni, Gavin
    Scaramozza, Matthew
    Campbell, Nolan
    Bradley, Daniel P.
    Franchimont, Nathalie
    Gafson, Arie
    Belachew, Shibeshih
    BMJ NEUROLOGY OPEN, 2022, 4 (01)
  • [33] Disease activity impacts disability progression in primary progressive multiple sclerosis
    Marrodan, M.
    Bensi, C.
    Pappolla, A.
    Rojas, J. I.
    Gaitan, M. I.
    Ysrraelit, M. C.
    Negrotto, L.
    Fiol, M. P.
    Patrucco, L.
    Cristiano, E.
    Farez, M. F.
    Correale, J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2020, 39
  • [34] Measuring disability progression in multiple sclerosis
    Achiron, Anat
    JOURNAL OF NEUROLOGY, 2006, 253 (Suppl 6) : 31 - 36
  • [35] Measuring disability progression in multiple sclerosis
    Anat Achiron
    Journal of Neurology, 2006, 253 : vi31 - vi36
  • [36] Effects of physical comorbidities on disability progression in multiple sclerosis
    Zhang, Tingting
    Tremlett, Helen
    Zhu, Feng
    Kingwell, Elaine
    Fisk, John D.
    Bhan, Virender
    Campbell, Trudy
    Stadnyk, Karen
    Carruthers, Robert
    Wolfson, Christina
    Warren, Sharon
    Marrie, Ruth Ann
    NEUROLOGY, 2018, 90 (05) : E419 - +
  • [37] Serum NSE level and disability progression in multiple sclerosis
    Koch, Marcus W.
    George, Suzanne
    Wall, Winona
    Yong, V. Wee
    Metz, Luanne M.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 350 (1-2) : 46 - 50
  • [38] Plasma lipid peroxidation and progression of disability in multiple sclerosis
    Koch, M.
    Mostert, J.
    Arutjunyan, A. V.
    Stepanov, M.
    Teelken, A.
    Heersema, D.
    De Keyser, J.
    EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (05) : 529 - 533
  • [39] Assessment of T2 lesion-based disease activity volume outcomes in predicting disease progression in multiple sclerosis over 10 years
    Oship, Devon
    Jakimovski, Dejan
    Bergsland, Niels
    Horakova, Dana
    Uher, Tomas
    Vaneckova, Manuela
    Havrdova, Eva
    Dwyer, Michael G.
    Zivadinov, Robert
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2022, 67
  • [40] Disability progression in aggressive multiple sclerosis
    Menon, Suresh
    Zhu, Feng
    Shirani, Afsaneh
    Oger, Joel
    Freedman, Mark S.
    Tremlett, Helen
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (03) : 456 - 463